Profile

Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Clinical Specialties

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor

Contact Information

Department: 336-716-4081

Media Medical Expert »

Related Links

Education & Training

  • B.S., University of Michigan/Ann Arbor, 1982
  • M.D., Cornell University Medical College, 1990
  • Ph.D., Rockefeller University, 1990
  • Residency, Surgery, Massachusetts Gen Hosp, 1996
  • Fellowship, Harvard Medical School, 1997

Board Certifications

  • American Board of Neurological Surgery, Neurological Surgery

NPI Number

  • 1831178151
Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Research Interests

Radiosurgery, Brain Neoplasms, Neoplasm Recurrence, Local, Meningioma, Trigeminal Neuralgia

Contact Information

Academic: 336-716-4047 | Department: 336-716-4081

Media Medical Expert »

Recent Publications

McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD. Emerging indications for fractionated gamma knife radiosurgery. Neurosurgery. 2017;80(2):210-216.

McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg. 2017;127(1):148-156.

McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD. Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. Neuro Oncol. 2017;19(4):558-566.

Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER. Stereotactic radiosurgical treatment of glomus jugulare tumors. Otol Neurotol. 2017;38(4):555-562.

Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. J Med Imaging Radiat Oncol. 2017;61(4):522-527.

McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD. Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. Am J Clin Oncol. 2017;():.

Chaunzwa TL, Deng D, Leuthardt EC, Tatter SB, Mohammadi AM, Barnett GH, Chiang VL. Laser thermal ablation for metastases failing radiosurgery: a multicentered retrospective study. Neurosurgery. 2017;():.

Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ,. Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. JCI Insight. 2017;2(7):e90133.

Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD. The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017;6(5):944-952.

Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR. Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. J Clin Neurosci. 2017;43():6-10.

Morykwas MJ, Argenta LC, Tatter SB, inventors; Wake Forest University Health Sciences, assignee. Application of localized sub-atmospheric pressure to the brain and spinal cord. Israel patent IL 206899. 2017 Mar 30. 2017;():.

Argenta LC, Morykwas MJ, Tatter SB, inventors; Wake Forest University Health Sciences, assignee. Device and method for treating central nervous system pathology. Australia patent AU 2.01E+09. 2017 Apr 20. 2017;():.

Renfrow JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ. Surgical considerations in the optimal management of patients with malignant brain tumors. Curr Treat Options Oncol. 2017;18(8):46.

Rossmeisl JH, Herpai D, Robertson JL, Dickinson PJ, Tatter SB, Debinski W. Tolerability and initial efficacy of convection-enhanced delivery of combinatorial IL-13RA2 and EPHA2 targeted cytotoxins to dogs with spontaneous intracranial malignant gliomas [abstract]. Neuro Oncol. 2017;19(Suppl 3):56.

Sonawane P, Herpai D, Ferluga S, Tatter SB, Debinski W. A single pharmaceutic agent for molecular resection of glioblastoma [abstract]. Neuro Oncol. 2017;19(Suppl 3):56.

Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT Jr, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D,. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram. J Neurooncol. 2017;():.

Johnston H, McTyre ER, Cramer CK, Lesser GJ, Ruiz J, Bourland JD, Watabe K, Lo HW, Qasem S, Laxton AW, Tatter SB, Chan MD. Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer. J Radiosurg SBRT. 2017;5(1):55-61.

Randolph DM, McTyre E, Klepin H, Peiffer AM, Ayala-Peacock D, Lester S, Laxton AW, Dohm A, Tatter SB, Shaw EG, Chan MD. Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes. J Radiosurg SBRT. 2017;5(1):35-42.

Swan BD, Brocker DT, Hilliard JD, Tatter SB, Gross RE, Turner DA, Grill WM. Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting. Clin Neurophysiol. 2016;127(2):1551-1559.

Zheng ZL, Morykwas MJ, Tatter S, Gordon S, McGee M, Green H, Argenta LC. Ameliorating spinal cord injury in an animal model with mechanical tissue resuscitation. Neurosurgery. 2016;78(6):868-876.

Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PE, Montague PR.. Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Proc Natl Acad Sci U S A. 2016;113(1):200-205.

Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS. Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Clin Neurol Neurosurg. 2016;140():38-42.

Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD. Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD. Genomic predictors of imaging response and survival in glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

Hughes RT, Black PJ, Page BR, Lucas JT, Qasem SA, Watabe K, Ruiz J, Laxton AW, Tatter SB, Debinski W, Chan MD. Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. J Radiosurg SBRT. 2016;4(2):89-96.

Lucas JT, Huang AJ, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictors of trigeminal nerve dysfunction following stereotactic radiosurgery for trigeminal neuralgia. J Radiosurg SBRT. 2016;4(2):117-123.

Rodriguez A, Tatter SB. Laser ablation of recurrent malignant gliomas: current status and future perspective. Neurosurgery. 2016;79(Suppl 1):S35-S39.

Randolph DM II, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg. 2016;151():73-78.

Chiang V, Dietrich J, Tatter S, Mohammadi A, Leuthardt E, Chamoun R, Judy K, Barnett G, Ahluwalia M. Laser ablation after stereotactic radiosurgery (LAASR) - results of a multi-centered prospective study [abstract]. Neuro Oncol. 2016;18(Suppl 6):31.

Wicks RT, Bandarage D, Mott RT, Strowd RE, Laxton AW, Tatter SB, Chan MD, Lesser GJ. Upfront chemoradiotherapy in grade 2 low grade glioma, a single institution experience [abstract]. Neuro Oncol. 2016;18(Suppl 6):14.

Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015;22(3):561-565.

Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536-542.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol. 2015;123(1):171-177.

Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Rodriguez A, Tatter SB. Neurosurgical management of brain metastases. Curr Probl Cancer. 2015;39(2):89-98.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015;6(22):18945-55.

Rodriguez A, Tatter SB, Debinski W. Neurosurgical techniques for disruption of the blood-brain barrier for glioblastoma treatment. Pharmaceutics. 2015;7(3):175-187.

Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW. Repeat radiosurgery for trigeminal neuralgia. Neurosurgery. 2015;77(5):755-761.

Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G. Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. J Clin Oncol. 2015;33(15 Suppl):e20669.

Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD. Factors that determine local control with gamma knife radiosurgery: the role of primary histology. J Radiosurg SBRT. 2015;3(4):281-286.

Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. J Neurooncol. 2015;124(3):447-453.

Smith CA, McTyre E, Isom S, Kennedy VE, Luo G, Morales-Paliza M, Hinson W, Cmelak AJ, Tatter SB, Chan MD, Attia A. A multi-institutional analysis of patients treated with stereotactic radiosurgery for brain metastases from radioresistant histologies [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3):E87-E88.

McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD. A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD. Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

Houseknecht K, Taksler GB, Johnson A, Page BR, Hinson W, Laxton AW, Tatter SB, Weaver KE, Chan MD, Ruiz J. Impact of socioeconomic status on brain metastasis outcomes at a large academic radiosurgery center [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E366.

Triffo WJ, Bourland JD, Couture DE, McMullen KP, Tatter SB, Morris PP. Definitive treatment of vein of Galen aneurysmal malformation with stereotactic radiosurgery. J Neurosurg. 2014;120(1):120-125.

Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014;120(3):433-441.

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurosurgery

Clinical Specialties

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor